Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
NEUROGESX INC
Jurisdiction of Incorporation/Organization
CA
Year of Incorporation/Organization
Over Five Years Ago
Previous Name(s)
- ADVANCED ANALGESICS, INC.
Item 2 Issuer Principal Place of Business and Contact Information
2215 BRIDGEPOINTE PARKWAY, SUITE 200
SAN MATEO, CA 94404
Phone Number:
subscription required
Item 3. Related Persons
Name
ANTHONY A. DITONNO
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
STEPHEN F. GHIGLIERI
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
JEFFREY K. TOBIAS
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
MICHAEL E. MARKELS
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
GARY A. LYONS
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
JEAN-JACQUES BIENAIME
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
NEIL M. KURTZ
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
ROBERT NELSEN
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
BRADFORD S. GOODWIN
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
JOHN A. ORWIN
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
STEVEN H. NELSON
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
PHARMACEUTICALS
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
08/05/2011
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
- Option, Warrant or Other Right to Acquire Another Security
- Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
0
Item 13. Offering and Sales Amounts
Total Offering Amount
1425000
Total Amount Sold
1425000
Total Remaining to be Sold
0
Clarification of Response
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
1
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
0.0
Finders' Fees
0.0
Clarification of Response
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
FUNDS TO BE USED FOR WORKING CAPITAL.
Signature and Submission
Issuer Name
NEUROGESX INC
Issuer Signature
/S/ MICHAEL J. O'DONNELL
Signer Name
MICHAEL J. O'DONNELL
Signer Title
SECRETARY
Signature Date
08/17/2011